Last reviewed: July 1, 2026
Last updated: July 1, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Many people ask whether they meet the weight threshold for semaglutide therapy, but the reality is more nuanced than a single number on the scale. The FDA approves semaglutide for chronic weight management in adults with a body mass index (BMI) of 30 kg/m² or higher, or a BMI of 27 kg/m² with at least one weight-related condition like type 2 diabetes, hypertension, or sleep apnea. PlexusDx evaluates your complete metabolic picture to determine whether GLP-1 therapy aligns with your health goals.
Standard BMI and Weight Requirements for GLP-1 Therapy
The primary qualification marker for semaglutide is your body mass index. Adults with a BMI of 30 kg/m² or greater meet the threshold for weight loss medication approval. This category includes most individuals classified as obese by medical standards. If your BMI falls between 27 and 29.9 kg/m², you may still qualify if you have at least one comorbid condition directly related to excess weight.
BMI alone tells an incomplete story about metabolic health. Two people with identical BMI values may have vastly different insulin sensitivity, inflammation levels, or genetic predispositions to weight gain. This is why PlexusDx focuses on individualized assessment rather than treating BMI as a fixed cutoff. Your practitioner reviews your complete medical history, current medications, and health markers to determine whether semaglutide is appropriate for your situation.
Weight-Related Conditions That Lower Your Eligibility Threshold
You don't need to reach a BMI of 30 to qualify for semaglutide if you have weight-related comorbidities. Type 2 diabetes, hypertension, cardiovascular disease, non-alcoholic fatty liver disease, and obstructive sleep apnea all count as qualifying conditions that lower your BMI threshold to 27 kg/m² or higher. These conditions signal that excess weight is already affecting your metabolic and cardiovascular systems, making earlier intervention medically justified.
Inflammation markers and lipid abnormalities also inform eligibility decisions. High triglycerides, low HDL cholesterol, elevated fasting glucose, or inflammatory markers like C-reactive protein indicate that your weight may be contributing to metabolic dysfunction. PlexusDx providers consider these laboratory values alongside your BMI to create a complete picture of your metabolic risk.
Medical History Factors That Affect Your Semaglutide Eligibility
Certain medical conditions and medications may affect whether semaglutide is safe or appropriate for you. A personal or family history of medullary thyroid cancer, multiple endocrine neoplasia type 2 (MEN2), pancreatitis, or severe gallbladder disease may exclude you from GLP-1 therapy. Similarly, if you are pregnant, breastfeeding, or planning pregnancy, semaglutide is not recommended. Your provider reviews all of these factors during the initial assessment.
Current medications and supplements also matter. Some drugs interact with semaglutide or may complicate weight loss therapy management. Certain insulin formulations, sulfonylureas, or other glucose-lowering agents require dose adjustment when you start a GLP-1 medication. PlexusDx practitioners conduct a comprehensive medication review before recommending treatment to ensure safety and efficacy.
How PlexusDx Personalizes Weight Loss Eligibility Assessment
PlexusDx goes beyond standard BMI cutoffs by incorporating genetic insights through the Precision Peptide Genetic Test. This peptide-pathway genetic assessment examines key variants like GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313—genes that influence how your body responds to GLP-1 medications and regulates appetite. Understanding your genetic predisposition helps your provider predict whether semaglutide will be effective for your specific metabolism.
The Precision Peptide Genetic Test maps 14 distinct metabolic pathways and 150+ genetic insights related to peptide signaling and weight regulation. This information allows PlexusDx to identify whether you're a strong responder to semaglutide, tirzepatide, or a dual-compound approach like GLP-Squared. Rather than guessing which medication suits you best, genetic testing removes uncertainty and supports faster, more effective treatment initiation. The test costs $99 as an add-on after your first month of treatment, making personalized eligibility assessment accessible without prohibitive upfront expense.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Do I need a specific weight to qualify for semaglutide with PlexusDx?
No. PlexusDx evaluates your BMI, comorbid conditions, laboratory markers, and medical history—not a single weight number. Most people with a BMI of 30 or higher, or a BMI of 27-29.9 with weight-related health conditions, qualify for semaglutide therapy. Your practitioner reviews your full profile during the initial consultation.
What if I have a BMI between 27 and 30? Can I still get semaglutide?
Yes, if you have at least one weight-related condition such as type 2 diabetes, hypertension, heart disease, sleep apnea, or elevated lipids. PlexusDx providers assess whether these comorbidities make semaglutide medically appropriate at your BMI level.
How does PlexusDx determine whether I'll respond well to semaglutide?
The Precision Peptide Genetic Test examines genetic variants that influence GLP-1 receptor signaling, appetite regulation, and weight metabolism. This $99 add-on test identifies your genetic predisposition to respond to semaglutide, tirzepatide, or dual-compound therapy, helping your provider choose the most effective medication from the start.
What medical conditions disqualify me from semaglutide therapy?
A personal or family history of medullary thyroid cancer, MEN2 syndrome, pancreatitis, or severe gallbladder disease typically disqualifies you. Pregnancy and breastfeeding also contraindicate semaglutide use. PlexusDx providers conduct a full medical history review to identify any contraindications before starting treatment.
How much does semaglutide cost at PlexusDx, and does it depend on my weight or dose?
Compounded Semaglutide Injection at PlexusDx starts at $149 per month, with no your dose may need to go up - your price won't advances—your dose may go up, but your price won't. PlexusDx serves all 50 states without insurance requirements, and treatment is HSA/FSA eligible.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Navigating Your Ozempic Journey: When Will It Start Working?
Optimizing Ozempic: Do You Take It Before or After Eating?